Literature DB >> 22355943

Seroprevalence of hepatitis B and C among barbers and their clients in the Rabat region of Morocco.

I Belbacha1, I Cherkaoui, M Akrim, K E Dooley, R El Aouad.   

Abstract

A cross-sectional seroepidemiological study was conducted in the Rabat-Salé-Zemmour-Zaër region of Morocco in 2007 among 267 barbers and 529 clients, all men with no history of hepatitis B (HBV) vaccination. The overall prevalence of HBV seropositivity was 28.1% in barbers and 25.1% in clients; 1.9% and 1.7% respectively had active HBV (HBsAg positive). Risk factors for HBV included older age, low educational level, urban living, being married, history of transfusion, lack of current heterosexual relationship and liver-associated symptoms. Observations showed that HBV seropositivity was lower in clean barbershops and those using alum as an antispetic. The rate of PCR-confirmed hepatitis C virus (HCV) was only 1.1% and 1.3% in barbers and clients respectively, and was associated with increased age, drug use, history of surgery and symptoms of liver disease. Less than 1% of barbers were aware of HBV or HCV as causative agents of liver disease or jaundice.

Entities:  

Mesh:

Year:  2011        PMID: 22355943     DOI: 10.26719/2011.17.12.911

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  9 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 2.  The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses.

Authors:  Fatima A Fadlalla; Yousra A Mohamoud; Ghina R Mumtaz; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

3.  Analysis of Knowledge, Attitudes, and Prevalence of Hepatitis B and C Seromarkers Among Barbers in Tehran.

Authors:  Tahereh Khairkhah; Ayat Shamsa; Azam Roohi; Jalal Khoshnoodi; Vand Fatemeh Rajabpour; Mina Tabrizi; Saeed Zarei; Forough Golsaz-Shirazi; Fazel Shokri
Journal:  Hepat Mon       Date:  2016-08-13       Impact factor: 0.660

4.  Knowledge, attitudes and prevention practices regarding HIV/AIDS among barbers in Ho municipality, Ghana.

Authors:  Mercy Quarm; Elvis Tarkang; Lilian Pencille; Prosper Lutala
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

5.  Knowledge, attitudes and prevention practices regarding HIV/AIDS among barbers in Ho municipality, Ghana.

Authors:  Mercy Demaris Quarm; Jacqueline Mthembu; Khangelani Zuma; Elvis Enowbeyang Tarkang
Journal:  SAHARA J       Date:  2021-12

6.  Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.

Authors:  Warda Baha; Abderrahim Foullous; Noureddine Dersi; Thierry Paluku They-they; Khadija El alaoui; Nadia Nourichafi; Bouchra Oukkache; Fatiha Lazar; Soumaya Benjelloun; My Mustapha Ennaji; Abdelouhad Elmalki; Hassan Mifdal; Abdelouaheb Bennani
Journal:  BMC Public Health       Date:  2013-01-18       Impact factor: 3.295

7.  High prevalence of hepatitis B and poor knowledge on hepatitis B and C viral infections among barbers: a cross-sectional study of the Obuasi municipality, Ghana.

Authors:  Prince Adoba; Stephen Kyei Boadu; Hope Agbodzakey; Daniel Somuah; Richard Kobina Dadzie Ephraim; Enoch Anto Odame
Journal:  BMC Public Health       Date:  2015-10-11       Impact factor: 3.295

Review 8.  Hepatitis C Virus in North Africa: An Emerging Threat.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Mohamed O Ahmed; Aghnyia A Dau; Mohamed M Agnan
Journal:  ScientificWorldJournal       Date:  2016-08-16

9.  Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco.

Authors:  Houda Haban; Soumia Benchekroun; Mina Sadeq; Abdelaziz Benjouad; Said Amzazi; Hicham Oumzil; Elmir Elharti
Journal:  BMC Public Health       Date:  2017-09-29       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.